402 related articles for article (PubMed ID: 21952330)
1. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services.
Oliphant J; Perkins N
N Z Med J; 2011 Jul; 124(1339):51-8. PubMed ID: 21952330
[TBL] [Abstract][Full Text] [Related]
2. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.
Ali H; Donovan B; Wand H; Read TR; Regan DG; Grulich AE; Fairley CK; Guy RJ
BMJ; 2013 Apr; 346():f2032. PubMed ID: 23599298
[TBL] [Abstract][Full Text] [Related]
3. Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme.
Chow EP; Read TR; Wigan R; Donovan B; Chen MY; Bradshaw CS; Fairley CK
Sex Transm Infect; 2015 May; 91(3):214-9. PubMed ID: 25305210
[TBL] [Abstract][Full Text] [Related]
4. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme.
Read TR; Hocking JS; Chen MY; Donovan B; Bradshaw CS; Fairley CK
Sex Transm Infect; 2011 Dec; 87(7):544-7. PubMed ID: 21970896
[TBL] [Abstract][Full Text] [Related]
5. The incidence of genital warts in Australian women prior to the national vaccination program.
Brotherton JM; Heywood A; Heley S
Sex Health; 2009 Sep; 6(3):178-84. PubMed ID: 19653953
[TBL] [Abstract][Full Text] [Related]
6. What can surveillance of genital warts tell us?
Fairley CK; Donovan B
Sex Health; 2010 Sep; 7(3):325-7. PubMed ID: 20719222
[TBL] [Abstract][Full Text] [Related]
7. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.
Donovan B; Franklin N; Guy R; Grulich AE; Regan DG; Ali H; Wand H; Fairley CK
Lancet Infect Dis; 2011 Jan; 11(1):39-44. PubMed ID: 21067976
[TBL] [Abstract][Full Text] [Related]
8. Trends in Male and Female Genital Warts Among Adolescents in a Safety-Net Health Care System 2004-2013: Correlation With Introduction of Female and Male Human Papillomavirus Vaccination.
Perkins RB; Legler A; Hanchate A
Sex Transm Dis; 2015 Dec; 42(12):665-8. PubMed ID: 26562694
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus vaccination and genital warts in young Indigenous Australians: national sentinel surveillance data.
Ali H; McManus H; O'Connor CC; Callander D; Kong M; Graham S; Saulo D; Fairley CK; Regan DG; Grulich A; Low N; Guy RJ; Donovan B
Med J Aust; 2017 Mar; 206(5):204-209. PubMed ID: 28301790
[TBL] [Abstract][Full Text] [Related]
10. Incidence of genital warts in adolescents and young adults in an integrated health care delivery system in the United States before human papillomavirus vaccine recommendations.
Camenga DR; Dunne EF; Desai MM; Gee J; Markowitz LE; Desiliva A; Klein NP
Sex Transm Dis; 2013 Jul; 40(7):534-8. PubMed ID: 23965766
[TBL] [Abstract][Full Text] [Related]
11. Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability.
Leval A; Herweijer E; Arnheim-Dahlström L; Walum H; Frans E; Sparén P; Simard JF
J Infect Dis; 2012 Sep; 206(6):860-6. PubMed ID: 22815381
[TBL] [Abstract][Full Text] [Related]
12. Near elimination of genital warts in Australia predicted with extension of human papillomavirus vaccination to males.
Korostil IA; Ali H; Guy RJ; Donovan B; Law MG; Regan DG
Sex Transm Dis; 2013 Nov; 40(11):833-5. PubMed ID: 24113401
[TBL] [Abstract][Full Text] [Related]
13. Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program.
Baandrup L; Blomberg M; Dehlendorff C; Sand C; Andersen KK; Kjaer SK
Sex Transm Dis; 2013 Feb; 40(2):130-5. PubMed ID: 23324976
[TBL] [Abstract][Full Text] [Related]
14. Genital warts and chlamydia in Australian women: comparison of national population-based surveys in 2001 and 2011.
Liu B; Donovan B; Brotherton JM; Saville M; Kaldor JM
Sex Transm Infect; 2014 Nov; 90(7):532-7. PubMed ID: 24570485
[TBL] [Abstract][Full Text] [Related]
15. Impact of quadrivalent human papillomavirus vaccine on genital warts in an opportunistic vaccination structure.
Lurie S; Mizrachi Y; Chodick G; Katz R; Schejter E
Gynecol Oncol; 2017 Aug; 146(2):299-304. PubMed ID: 28602548
[TBL] [Abstract][Full Text] [Related]
16. The prophylactic role for the human papillomavirus quadrivalent vaccine in males.
Yancey AM; Pitlick JM; Forinash AB
Ann Pharmacother; 2010; 44(7-8):1314-8. PubMed ID: 20501891
[TBL] [Abstract][Full Text] [Related]
17. Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women.
Fairley CK; Hocking JS; Gurrin LC; Chen MY; Donovan B; Bradshaw CS
Sex Transm Infect; 2009 Dec; 85(7):499-502. PubMed ID: 19837728
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study.
Dominiak-Felden G; Gobbo C; Simondon F
PLoS One; 2015; 10(7):e0132404. PubMed ID: 26147096
[TBL] [Abstract][Full Text] [Related]
19. Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination programme: an analysis of national sentinel surveillance data from 2004-18.
Chow EPF; Carter A; Vickers T; Fairley CK; McNulty A; Guy RJ; Regan DG; Grulich AE; Callander D; Khawar L; Machalek DA; Donovan B
Lancet Infect Dis; 2021 Dec; 21(12):1747-1756. PubMed ID: 34339639
[TBL] [Abstract][Full Text] [Related]
20. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):630-2. PubMed ID: 20508594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
